Neutral
Passage Bio And Remix Therapeutics Announce Merger Agreement
Passage Bio and Remix Therapeutics have announced a merger agreement. This news was reported by Refinitiv via Reuters. The full details of the agreeme...
PASG
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (1)
Neutral (1)
Bearish (0)
Latest PASG News
Bullish
Passage Bio to Merge With Remix Therapeutics; Remix Valued at $226M, $100M Financing
Passage Bio has signed a definitive merger agreement to acquire Remix Therapeutics in a stock-for-stock deal, valuing Remix at $226 million and Passag...
Research PASG on:
Ad Space